Abstract:Objective To explore novel compensatory mutations in the reverse transcriptase(RT) region of the hepatitis B virus(HBV) associated with rtM204I/V drug-resistant mutation.Methods Three hundred and ninety-two RT sequences of genotype C HBV from chronic hepatitis B patients in the database of our department were analyzed.392 patients were divided into untreated group(n=192),lamivudine(LMV),telbivudine(LdT) or entecavir(ETV)-treated group without rtM204I/V mutation(rtM204 group,n=131) and the treated group with rt204I/V mutation(rtM204I/V group,n=69).Data analysis was done using our previously developed software based on Microsoft Office Excel 2007 and other common bioinformatics tools.Each of the 344 amino acid site in the RT region of the HBV was screened and analyzed to identify potentialcompensatory mutations associated with rtM204I/V drug-resistant mutation.ResultsIn addition to the common published mutations rtL80I/V and rtL180M,we identified a novel mutation at rtH55R which also frequently associated with the rtM204I/V drug-resistant mutation.rtH55R mutation in rtM204I/V group was significantly higher than that in the rtM204 group and the untreated group(36.23% vs 9.16% and 4.17%,respectively;P0.001).Among 25 HBV strains harboring combined rtH55R+rtM204I/V mutations,22(88.00%) were found rtL80I/V or rtL180M mutations as well,while the remaining 3(12.00%) bear rtH55R+rtM204I mutation.The serum HBV DNA titers in patients carrying rtH55R+rtM204I mutant HBV were higher than 5 lg copies/ml;this mutant could be detected in patients treated with different antiviral therapies including single,sequential or combination treatments including lamivudine,adefovir dipivoxil and entecavir.Interestingly,rtH55 is a genotype C-specific site,while it is rtR55 at this site in other HBV genotypes.ConclusionsRtH55R was identified as a novel genotype C specific mutation associated with rtM204I/V drug-resistance.HBV strains carrying rtH55R+rtM204I/V mutations can survive through different antiviral therapies during the hepatitis B treatment.

A Novel Reverse Transcriptase Mutation in Genotype C Hepatitis B Virus Associated with Rtm204i/v Drug Resistant Mutation